BOSTON, Oct. 20, 2021 /PRNewswire/ -- Ginkgo
Bioworks Inc. (NYSE: DNA) ("Ginkgo"), which is building the leading
horizontal platform for cell programming, announced today that
management is scheduled to present at the Jefferies Gene
Therapy/Editing Summit on Wednesday,
October 27, 2021 at 3:00p.m. Eastern
Time.
The webcast link and replay of the presentation can be found
below as well as on the company's investor relations website at
https://investors.ginkgobioworks.com.
Webcasting
information: https://wsw.com/webcast/jeff208/register.aspx?conf=jeff208&page=gibi&url=https://wsw.com/webcast/jeff208/gibi/1821975
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program
cells as easily as we can program computers. The company's platform
is enabling biotechnology applications across diverse markets, from
food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo has also actively supported a number of COVID-19 response
efforts, including K-12 pooled testing, vaccine manufacturing
optimization and therapeutics discovery. For more information,
visit www.ginkgobioworks.com.
MEDIA CONTACT:
press@ginkgobioworks.com
INVESTOR CONTACT:
investors@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-jefferies-gene-therapyediting-summit-301404504.html
SOURCE Ginkgo Bioworks